MABLIFE
🏢 View company profile →3Patents
3Active
3Granted
40Portfolio score
Filing activity: Jun 14, 2006 → Jun 2, 2015 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8409573B2 | Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells | Chemistry; Metallurgy | 6 | Active |
| US10208124B2 | Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis | Chemistry; Metallurgy | 4 | Active |
| US9045544B2 | Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.